- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07657559
RCT - Suprapatellar Approach Versus Lateral Parapatellar Approach in Tibial Shaft Fracture (ELPP)
June 14, 2026 updated by: Queen Savang Vadhana Memorial Hospital, Thailand
Comparison of Suprapatellar Approach Versus Extra-articular Lateral Parapatellar Approach in Tibial Shaft Fractures: A Randomized Controlled Trial
This study aims to compare 2 surgical techniques for tibial shaft nailing (suprapatellar approach vs extra-articular lateral parapatellar approach).
following peri-operative and postoperative outcomes
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
This is a randomized controlled trial study, compared extra-articular lateral parapatellar approach with suprapatellar approach in tibial shaft nailing.
peri-operative data are operative time, blood loss, fluoroscopy time, hospital stay.
post-operative outcomes include Lysholm Knee Score, VAS-knee, range of motion.
these outcomes are following postoperative day 1, 2 weeks, 6 weeks, 3 months and 6 months.
Study Type
Interventional
Enrollment (Estimated)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Tiwat Wongkasemjit M.D., Resident
- Phone Number: +66893146833
- Email: toytiwat@gmail.com
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- age 18-60 years
- tibial shaft fractures
Exclusion Criteria:
- pervious knee injury
- open fracture at least Gustilo grade II
- ipsilateral femur and ankle fractures
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: suprapatellar approach
|
semi-extended position longitudinal incision 2 cm.
above patella nail insertion procedure under patellofemoral joint
|
|
Experimental: extra-articular lateral parapatellar approach
|
semi-extended position longitudinal incision 4-5 cm., lateral to patellar tendon nail insertion procedure
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Lysholm Knee Score
Time Frame: 6 months
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
operative time
Time Frame: operation
|
operation
|
|
|
VAS score of knee
Time Frame: POD 1, 2 weeks, 6 weeks, 3 months, 6 months
|
POD 1, 2 weeks, 6 weeks, 3 months, 6 months
|
|
|
range of motion
Time Frame: POD 1, 2 weeks, 6 weeks, 3 months, 6 months
|
knee
|
POD 1, 2 weeks, 6 weeks, 3 months, 6 months
|
|
intraoperative blood loss
Time Frame: operation
|
operation
|
|
|
fluoroscopy time
Time Frame: operation
|
operation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
August 1, 2026
Primary Completion (Estimated)
August 1, 2026
Study Completion (Estimated)
August 31, 2028
Study Registration Dates
First Submitted
June 14, 2026
First Submitted That Met QC Criteria
June 14, 2026
First Posted (Actual)
June 18, 2026
Study Record Updates
Last Update Posted (Actual)
June 18, 2026
Last Update Submitted That Met QC Criteria
June 14, 2026
Last Verified
June 1, 2026
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 016/2567
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
IPD Plan Description
data was save in form of Microsoft excel spreadsheet and SPSS file
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.